| Intrinsic Valuation of: GLAXO | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 60 | Market Cap | ₹413B | |||||
| 2021 | - | - (-) | P/E Ratio | 41 | Total Asset | ₹41B | |||||
| 2022 | ₹8B | - (-) | Net Income | ₹9B | Total Debt | ₹0 | |||||
| 2023 | ₹4B | -43.3% (-42.6%) | EBITDA | ₹13B | Total Liab | ₹22B | |||||
| 2024 | ₹6B | 25.1% (17.3%) | Opr Margin | 29.91 | Debt/Equity | - | |||||
| 2025 | ₹13B | 129.7% (112.2%) | PreTax Margin | 29.87 | BV/Share | 114 | |||||
| 5Y Average FCF | ₹8B | 15.0% (29.0%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | ₹13B | MBG Intrinsic Value | ₹536 | ||||||||
| 2027 | ₹14B | ||||||||||
| 2028 | ₹16B | ||||||||||
| 2029 | ₹17B | ||||||||||
| 2030 | ₹18B | ||||||||||
| 2031 | ₹18B | ||||||||||
| Terminal Value | ₹415B | Net Worth/Share | ₹115 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹352B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹5B | ₹2,110 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 6.5% | 1,982 | 2,156 | 2,373 | 2,652 | 3,023 | |||
| Equity Value | ₹358B | 7.1% | 1,763 | 1,895 | 2,056 | 2,255 | 2,510 | ||||
| Shares Outstanding | 169,406,034 | 7.8% | 1,584 | 1,687 | 1,810 | 1,958 | 2,140 | ||||
| 8.4% | 1,439 | 1,520 | 1,616 | 1,730 | 1,866 | ||||||
| DCF Intrinsic Value | ₹2,110 | 9.0% | 1,319 | 1,386 | 1,462 | 1,552 | 1,658 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||